Baseline CD4 and mortality trends in the South African human immunodeficiency virus programme: Analysis of routine data
Open Access
- 24 July 2019
- journal article
- Published by AOSIS in Southern African Journal of HIV Medicine
- Vol. 20 (1) , 10
Abstract
The Southern African Journal of HIV Medicine is focused on HIV/AIDS treatment, prevention and related topics relevant to clinical and public health practice. The purpose of the journal is to disseminate original research results and support high-level learning related to HIV Medicine. It publishes original research articles, editorials, case reports/case series, reviews of state-of-the-art clinical practice and correspondence.Keywords
This publication has 44 references indexed in Scilit:
- Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort StudiesPLOS Medicine, 2013
- Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South AfricaPLOS ONE, 2013
- Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countriesAIDS, 2011
- Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costsPatient Preference and Adherence, 2011
- Trends in the clinical characteristics of HIV‐infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009Journal of the International AIDS Society, 2011
- HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing dataBulletin of the World Health Organization, 2010
- Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South AfricaAIDS, 2010
- One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjectsPatient Preference and Adherence, 2010
- Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohortThe Lancet, 2010
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004